Margaret Dow Moore

Title: Margaret Dow Moore: Pioneer in HSV-2 Vaccine Development

Introduction: Margaret Dow Moore is a distinguished inventor based in Seattle, WA, with a remarkable portfolio of 19 patents to her name. Her work primarily focuses on innovative vaccine compositions aimed at preventing and treating infections, particularly focusing on the herpes simplex virus type 2 (HSV-2).

Latest Patents: Among her latest contributions to the field of medicine, Moore has developed advanced vaccines for HSV-2. These inventions include compositions of recombinant HSV-2 proteins paired with agonists of the innate immune system, such as adjuvants. The innovative vaccines contain essential proteins, including an envelope glycoprotein and other structural proteins like capsid or tegument proteins, suitable for use in both HSV-2 seropositive and seronegative subjects. This significant advancement embodies a critical step forward in vaccine research and development aimed at managing HSV-2 infections.

Career Highlights: Throughout her career, Margaret has worked with reputable organizations, including Zymogenetics, Inc. and Immune Design Corporation. Her contributions to the industry have established her as a prominent figure in the realm of immunology and vaccine innovation.

Collaborations: In her endeavors, Moore has collaborated with notable colleagues such as Brian A. Fox and Wenfeng Xu. Their collective expertise has propelled the research and development of her inventive vaccine solutions, showcasing the importance of teamwork in advancing medical science.

Conclusion: In conclusion, Margaret Dow Moore stands out as an influential inventor in the field of vaccine development, particularly for HSV-2. Her innovative patents and collaborative efforts underline her commitment to improving health outcomes through significant advancements in immunology. Her ongoing contributions to the field continue to inspire future research and innovation.